All Categories
Minicircle DNA

Minicircle DNA

Home >  Modality  >  Nucleic Acids  >  Minicircle DNA

Modality

Minicircle DNA

Minicircle DNA (mcDNA) is a smaller non-viral DNA vector derived from a parental plasmid DNA-like structure. Minicircle DNA differs from conventional plasmid DNA in that it contains promotor and gene of interest (GOI), without origin of replication (ORI) and selection marker (selMark). Minicircle DNA is produced in bacteria through in vivo recombination to remove extra sequences (called mini-plasmid) from plasmid DNA. Due to its safety, minicircle DNA has gained popularity as a non-viral vector for gene therapy, DNA vaccines, etc.

图片

Figure 1. Structure of Plasmid DNA (pDNA) and Minicircle DNA (mcDNA)

Minicircle DNA Recombination Systems

There are four main minicircle DNA in vivo recombination systems that have been studied, including Phage λ integrase, Phage P1 Cre recombinase, ParA resolvase, PhiC31 integra se/I-SceI.

Strategy

Phage λ integrase

Phage P1 Cre recombinase

ParA resolvase

PhiC31 integra se/I-SceI

Mechanism

Tyrosine recombinase, which functions through proteins FIS and IHF to catalyze the recombination of att hybrid sites

Site-specific tyrosine recombinase, which performs a bidirectional recombination when binding to loxP sites

Serine recombinase, which performs an irreversible and unidirectional recombination between two identical MRSsites

Serine recombinase, which mediates unidirectional recombination between attP/attB binding sites, while I-SceI endonuclease cleaves the product-related impurities and unrecombined parental plasmid

Features

Depend on the expression of host factors FIS and IHF; intrinsic toxicity; Residual parental plasmid and mini-plasmid

Residual parental plasmid and mini-plasmid

High yield; Residual parental plasmid and mini-plasmid

Degradation of parental plasmid associated reduced yield

Yaohai Bio-Pharma Offers One-Stop CDMO Solution for Minicircle DNA
Reference:

[1] Almeida AM, Queiroz JA, Sousa F, Sousa Â. Minicircle DNA: The Future for DNA-Based Vectors? Trends Biotechnol. 2020 Oct;38(10):1047-1051. doi: 10.1016/j.tibtech.2020.04.008.

Get a Free Quote

Get in touch